News
PureTech Launches Seaport Therapeutics With $100M Oversubscribed Series A; Daphne Zohar Steps Down To Lead Seaport; Bharatt Chowrira Appointed New CEO
9 Apr 24
News
PureTech Proposes $100M Capital Return Via a Tender Offer at 250 Pence/Share
19 Mar 24
News
PureTech Founded Entity Akili Announces Results from Shionogi's Phase 3 Clinical Trial of Localized Version of Akili's EndeavorRx for Pediatric ADHD Patients in Japan
27 Feb 24
Government, News, Regulations
Press releases
PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis
16 Apr 24
Press Releases
PureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers
11 Apr 24
Press Releases
PureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions
9 Apr 24
Press Releases
PureTech Receives Orphan Drug Designation for LYT-200 in Acute Myeloid Leukemia
13 Mar 24
Press Releases
PureTech to Present at Two Upcoming Investor Conferences
27 Feb 24
Press Releases
PureTech Founded Entity Akili Announces Positive Results from Shionogi's Phase 3 Clinical Trial of Localized Version of Akili's EndeavorRx ® for Pediatric ADHD Patients in Japan
27 Feb 24
Press Releases